Optimizing Kinetics Assays to Avoid Avidity Effects
A fundamental understanding of the differences between affinity and avidity is essential when designing and developing assays. This application note discusses the phenomena of affinity and avidity as measured on the Octet® Bio-Layer Interferometry (BLI) platform and how to recognize and resolve issues arising from interactions that contain a bivalent or multivalent component.
Assay design plays a critical role in the ability to determine the correct binding kinetics and affinity values and therefore, key parameters including assay orientation, valency (mono- or multivalent), ligand surface density and non-specific binding (NSB) are discussed. A robust assay design helps to limit assay artifacts and promotes the determination of the desired binding kinetics and affinity. Affinity and avidity are closely related parameters, which when considered early in assay design can ensure the user can generate the desired assay parameters between the interacting molecules.
Access Application Note
Page Count: 13Read Time: 30 minutesLast Updated: October 24, 2022Authors: Tim Heiseler, PhD, Michael Metterlein, Gail Calvert, Philip Buckle, Stuart Knowling, PhD, Bob Dass, PhD, Lisette Bronswijk-Deddens, PhDTarget Audience: Biopharma, Biotech, Pharma QCApplications Covered: Cell Line Development
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.
Shop Sartorius Products Now